27 Jun. 2017
WILMINGTON, N.C., (June 27, 2017) – Pharmaceutical Product Development, LLC (PPD) today announced it has appointed Christopher C. Fikry, M.D., as executive vice president of PPD® Laboratories.
PPD Laboratories offers the most comprehensive set of laboratory services in the industry, spanning bioanalytical, biomarkers, central lab, GMP and vaccine sciences. From preclinical studies through late stage research, PPD Laboratories’ services are designed to accelerate development for small molecules, biologics and vaccines.
“Chris will apply his extensive industry experience and leadership skills to guide the continued growth of our laboratory business by ensuring exceptional quality and service for our clients,” said William Sharbaugh, chief operating officer for PPD. “With pharmaceutical and biotech companies’ needs in clear focus, Chris and our talented lab teams will continue to bring our clients world-class scientific expertise, state-of-the-art technology and a commitment to innovation in helping develop new life-changing therapies.”
Fikry joins PPD from Quest Diagnostics, where he served most recently as vice president and general manager for oncology and companion diagnostics. He took on this role after having served as vice president of clinical trials, a role in which he led the company’s central laboratory, biomarker and companion diagnostic services.
Previously, Fikry was with Novartis Vaccines and Diagnostics, Inc., where he developed a track record of success in a variety of roles, including director of strategic planning, head of U.S. influenza, travel vaccine and meningococcal vaccine franchises and commercial leadership roles, including vice president of U.S. marketing. He began his career as a project leader with The Boston Consulting Group.
Fikry earned a bachelor’s degree in biology from New York University and a medical degree and MBA from the University of Pennsylvania.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and more than 19,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health.
+1 910 558 6096
+1 910 558 6783